Home/Filings/4/0001179110-20-002187
4//SEC Filing

Ryll Thomas 4

Accession 0001179110-20-002187

CIK 0000855654other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:38 AM ET

Size

4.9 KB

Accession

0001179110-20-002187

Insider Transaction Report

Form 4
Period: 2020-02-24
Ryll Thomas
VP, Technical Operations
Transactions
  • Sale

    Common Stock

    2020-02-24$4.99/sh16,790$83,78275,624 total
Footnotes (2)
  • [F1]Weighted average price of shares sold.
  • [F2]The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001701531

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:38 AM ET
Size
4.9 KB